← All Neuronetics, INC filings

Neuronetics, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
STIM
Neuronetics, INC
SCHEDULE: Point72 Entities Acquire 5% Stake in Neuronetics
Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have jointly filed to report beneficial ownership of 5.0% of Neuronetics, Inc. common stock.
NASDAQ
STIM
Neuronetics, INC
SCHEDULE: Jorey Chernett Discloses 10.85% Stake in Neuronetics
Jorey Chernett has reported a beneficial ownership of 10.85% of Neuronetics, Inc.'s common stock as of March 17, 2026.
NASDAQ
STIM
Neuronetics, INC
SCHEDULE: Parian Ultreia LP Discloses 7% Stake in Neuronetics
Parian Ultreia LP has reported a 7.0% beneficial ownership stake in Neuronetics, Inc., holding 4,844,908 shares with sole voting and dispositive power.
NASDAQ
STIM
Neuronetics, INC
SCHEDULE: Chernett Jorey Boosts Neuronetics Stake to 9.97%
Jorey Chernett has reported an amended beneficial ownership of 9.97% in Neuronetics, Inc., holding 6,827,031 common shares.
NASDAQ
STIM
Neuronetics, INC
SCHEDULE: Jorey Chernett Discloses 6.4% Stake in Neuronetics
Jorey Chernett has reported a 6.4% beneficial ownership stake in Neuronetics, Inc., holding 4,403,498 common shares as a passive investor.
NASDAQ
STIM
Neuronetics, INC
SCHEDULE 13G/A: Kent Lake Entities Report Full Divestment of Neuronetics, Inc. Shares
Kent Lake PR LLC, Kent Lake Partners LP, and Benjamin Natter have filed an amended Schedule 13G, indicating they no longer hold any beneficial ownership in Neuronetics, Inc. as of December 31, 2024.